cefixime and ro13-9904

cefixime has been researched along with ro13-9904 in 145 studies

Research

Studies (145)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (2.76)	18.7374
1990's	16 (11.03)	18.2507
2000's	18 (12.41)	29.6817
2010's	68 (46.90)	24.3611
2020's	39 (26.90)	2.80

Authors

Authors	Studies
Agoki, E; D'Costa, LJ; Ndinya-Achola, JO; Ombette, J; Plourde, PJ; Plummer, FA; Slaney, LA; Tyndall, M	1
Holdcroft, C	1
Covino, JM; Douglas, JM; Ehret, JM; Handsfield, HH; Hook, EW; McCormack, WM; Reichart, CA; Verdon, MS	1
Cates, W; Hinman, AR	1
Himes, SL; Mortensen, JE	1
Regnier, B	1
Noel, GJ; Teele, DW	1
Knapp, CC; Sierra-Madero, J; Washington, JA	1
Cullmann, W; Dick, W; Opferkuch, W; Stieglitz, M	1
Farid, Z; Girgis, NI; Hammad, O; Sultan, Y	1
Vartiovaara, I	1
Bhutta, ZA; Khan, IA; Molla, AM	1
Biro, FM; Friedland, LR; Kulick, RM; Patterson, A	1
Dancy, RM; Day, SW; Harris, SC; Wang, WC; Wilimas, JA; Williams, LL	1
Amir, J; Eidlitz-Markus, T; Harel, L; Varsano, I	1
de Bruine, AP; Peters, FP; Stockbrügger, RW; Wouters, RS	1
Bhutta, ZA; Hussain, R; Mansoorali, N	1
Verbist, L; Verhaegen, J	1
Nikoskelainen, J; Oksi, J; Viljanen, MK	1
Agbaba, D; Eric-Jovanovic, S; Vladimirov, S; Zivanov-Stakic, D	1
Barash, JR; Janda, JM; Sandfort, RF; Wong, JD	1
Ambrose, PG; Nicolau, DP; Nightingale, CH; Owens, RC; Quintiliani, R; Tessier, P	1
Mayfield, JA; Ramus, RM; Sheffield, JS; Wendel, GD	1
Joshi, VR; Mehta, A; Rodrigues, C	1
Collvinent, B; Horcajada, JP; Marco, F; Mensa, J; Millá, J; Miró, O; Moreno, A; Sanchez, M	1
Levenson, D	2
Castello, B; Cohen, R; de La Vaissière, B; Grimprel, E; Quinet, B	1
Little, JW	1
Marth, T	1
Fredlund, H; Lindberg, R; Nicholas, R; Unemo, M	1
Deguchi, T; Ito, S; Kubota, Y; Maeda, S; Ozawa, T; Tamaki, M; Yasuda, M; Yokoi, S	1
Furuya, R; Iyoda, T; Kanayama, A; Kobayashi, I; Matsuzaki, K; Onoye, Y; Saika, T; Tanaka, M; Tatewaki, M	1
Bacelle, L; Chiesa, G; Dalla Vestra, M; Marcon, L; Patrassi, GM; Rettore, C; Sartore, P; Sasset, L; Scarano, L; Simioni, N; Velo, E	1
Endo, K; Kiyota, H; Narukawa, K; Onodera, S; Osaka, K; Takahata, M; Takakura, T	1
Tapsall, JW	1
Davies, C; Duncan, M; Nicholas, RA; Tomberg, J; Unemo, M; Zhao, S	1
Beksaç, MS; Katlan, D; Kir, S; Nemutlu, E	1
Chong, Y; Chung, GT; Jeong, SH; Lee, H; Lee, K; Lee, SG; Lee, YS; Yong, D	1
Brill, JR	1
Ojani, R; Raoof, JB; Zamani, S	1
Davies, C; Nicholas, RA; Tomberg, J; Unemo, M	1
Fredlund, H; Golparian, D; Hellmark, B; Unemo, M	1
Jacobsson, S; Nissen, MD; Sloots, TP; Tapsall, JW; Unemo, M; Whiley, DM	1
Klingler, A	1
Allen, VG; Farrell, DJ; Lo, S; Low, DE; Melano, RG; Perusini, SJ; Rebbapragada, A; Tan, J; Tijet, N; Towns, L	1
Golparian, D; Moi, H; Syversen, G; Unemo, M; Vestrheim, DF	1
Hogan, T; Kahlmeter, J; Lam, A; Limnios, A; Ray, S; Tapsall, J; Unemo, M	1
Antonetti, R; Carannante, A; Cavrini, F; Cusini, M; D'Antuono, A; Dal Conte, I; Ghisetti, V; Matteelli, A; Prignano, G; Stefanelli, P	1
Alexander, S; Ison, CA	1
Bala, M	1
Gallay, A; Golparian, D; Nicholas, R; Ohnishi, M; Sednaoui, P; Unemo, M	1
Bocquet, N; Chéron, G; Gajdos, V; Guigonis, V; Jais, JP; Lacour, B; Sergent Alaoui, A	1
Allen, V; Gilmour, M; Hoang, L; Lefebvre, B; Martin, I; Mina, N; Sawatzky, P; Wong, T	1
Bai, ZG; Bao, XJ; Cheng, WD; Li, YP; Yang, KH	1
Deguchi, T; Ito, S; Yasuda, M	1
Bolan, G; Kidd, S; Kirkcaldy, R; Weinstock, H	1
Cole, MJ; Ison, CA; Pereira, R	1
Maldonado, NG; Takhar, SS	1
Chisholm, S; Hughes, G; Ison, CA; Livermore, DM; Lowndes, CM; Obi, C; Town, K	2
Azadian, B; Wright, DJ	1
Fasih, N; Irfan, S; Khan, E; Qaiser, S; Sultan, BA; Zafar, A	1
Dorin, M; Kawahata, T; Morita-Ishihara, T; Nakayama, S; Ohnishi, M; Shimuta, K; Unemo, M	1
Drews, SJ; Gratrix, J; Lovgren, M; Martin, I; Read, R; Romanowski, B; Singh, AE; Sutherland, K; Talbot, J	1
Katz, AR; Kidd, S; Kirkcaldy, RD; Komeya, A; Kunimoto, G; Lee, MV; Maningas, E; O'Connor, N; Wasserman, GM; Whelen, AC	1
Brooks, B; Cole, M; Patel, R; Ross, JD; Unemo, M; White, JA	1
de Melo Oliveira, MD; Hauser, P; Kovari, H; Läuchli, S; Meyer, J; Weber, R; Zbinden, R	1
Dillon, JA; Horsman, GB; Levett, PN; Thakur, SD	1
Dillon, JR; Horsman, GB; Levett, PN; Starnino, S; Thakur, SD	1
Endimiani, A; Furrer, H; Guilarte, YN; Hauser, C; Hirzberger, L; Lupo, A; Selvini, S; Tinguely, R	1
Berçot, B; Cambau, E; La Ruche, G; Sednaoui, P; Semaille, C	1
Deguchi, T; Ito, S; Tsuchiya, T; Yasuda, M; Yokoi, S	1
Donovan, B; Lahra, MM; Whiley, DM	1
Barbee, LA	1
Furubayashi, K; Kawahata, T; Morita-Ishihara, T; Nakayama, S; Ohnishi, M; Shimuta, K; Unemo, M	1
Chisholm, SA; Cole, MJ; Hoffmann, S; Ison, CA; Spiteri, G; Unemo, M; Van de Laar, M	1
Cheng, CW; Li, LH; Li, SY; Su, CY; Yen, MY	1
Amato-Gauci, AJ; Chisholm, SA; Cole, MJ; Hoffmann, S; Ison, CA; Spiteri, G; Town, K; Unemo, M; van de Laar, M	1
Akiyama, K; Arakawa, S; Chokyu, H; Egawa, S; Fujisawa, M; Hamasuna, R; Hanaki, H; Hayami, H; Hirayama, H; Hosobe, T; Imai, T; Ishikawa, K; Ito, K; Ito, M; Ito, S; Iwata, S; Kadena, H; Kadota, J; Kaji, S; Kaku, M; Kano, M; Kawahara, M; Kawai, S; Kiyota, H; Kobayashi, K; Kumon, H; Kuroiwa, K; Maeda, S; Matsubara, A; Matsumoto, T; Matsumura, M; Minamitani, S; Monden, K; Naito, S; Narita, H; Nishi, S; Nishimura, H; Sato, J; Shirane, T; Sumii, T; Sunakawa, K; Takahashi, S; Takayama, K; Tanaka, K; Tsukamoto, T; Uehara, S; Uno, S; Watanabe, A; Yamaguchi, T; Yamamoto, S; Yasuda, M; Yoh, M; Yoshioka, M	1
Cole, M; Fredlund, H; Jacobsson, S; Ringlander, J; Unemo, M; Wiggins, C	1
Bogdan, M; Hećimović, I; Vuković, D; Zujić Atalić, V	1
Mahboob, A; Nazeer, SH; Nizammudin, S; Raza, A; Sultan, F	1
Saeed, NK	1
Galarza, P; Gianecini, R; Oviedo, C; Stafforini, G	1
Antonetti, R; Carannante, A; Cusini, M; Ghisetti, V; Latino, MA; Leli, C; Matteelli, A; Ober, P; Poletti, F; Prignano, G; Stefanelli, P; Vacca, P; Vocale, C	1
Amarsy, R; Bercot, B; Cambau, E; de Curraize, C; Fournet, N; Goubard, A; Jacquier, H; Kumanski, S; La Ruche, G; Meunier, F; Micaëlo, M	1
Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M	1
Brunner, A; Jeney, C; Karpati, S; Marschalko, M; Nemes-Nikodem, E; Ostorhazi, E; Szabo, D	1
Abrams, JA; Barros Dos Santos, KT; Bonelli, RR; Coelho-Souza, T; Costa-Lourenço, APR; Fracalanzza, SEL; Moreira, BM; Trees, DL	1
Chen, SC; Chen, XS; Dai, XQ; Han, Y; Yin, Y; Yu, RX; Zhang, GY; Zheng, BJ	1
Alpay, H; Altuntaş, Ü; Bıyıklı, N; Çiçek, N; Gökçe, İ; Güven, S; Yıldız, N	1
Chakanyuka Musanhu, C; Gudza-Mugabe, M; Gwanzura, L; Latif, AS; Machiha, A; Ndowa, F; Shukusho, FD; Tarupiwa, A; Unemo, M; Wi, T	1
Galarza, P; Gianecini, R; Oviedo, C; Romero, MLM; Vacchino, M	1
Amato-Gauci, AJ; Cole, MJ; Jacobsson, S; Spiteri, G; Tripodo, F; Unemo, M; Woodford, N	1
Dillon, JR; Horsman, GB; Levett, PN; Thakur, SD	1
Glennen, A; Hagan, C; Iwen, PC; Lee, LV; O'Connor, NP; Papp, JR; Razeq, JH; Rowlinson, MC; Ware, D; Wholehan, J	1
Bremer, V; Buder, S; Dudareva, S; Guhl, E; Jansen, K; Kohl, PK; Loenenbach, A; Nikisins, S; Sailer, A	1
Comunián-Carrasco, G; Martí-Carvajal, AJ; Peña-Martí, GE	1
Cole, MJ; Ison, C; Woodford, N	1
Furuya, R; Kanesaka, I; Katsuse, AK; Kobayashi, I; Ohno, A; Tanaka, M	1
Amato-Gauci, AJ; Cole, MJ; Day, MJ; Jacobsson, S; Spiteri, G; Unemo, M; Woodford, N	1
Davies, C; Nicholas, RA; Singh, A; Tomberg, J	1
Deng, X; Klausner, JD	1
Majewska, A; Majewski, S; Malejczyk, M; Młynarczyk, G; Młynarczyk-Bonikowska, B	1
Indriatmi, W; Nilasari, H; Prayogo, RL; Suseno, LS	1
Dobre-Buonya, O; Kilic, A; McNeil, CJ; Palavecino, EL; Schmerer, MW; Toler, C	1
Hamill, MM; Kajumbula, H; Kakooza, F; Kyambadde, P; Lamorde, M; Manabe, YC; Mande, E; Mbabazi, O; Mugasha, R; Musinguzi, P; Wagner, J; Walwema, R; Workneh, M; Zenilman, J	1
Borrego, MJ; Duarte, S; Gomes, JP; Gonçalves, I; Gonçalves, MJ; Matias, R; Pinto, M; Ramos, MH; Rodrigues, JC; Vieira, L	1
Buder, S; Dudareva, S; Eckardt, M; Gassowski, M; Graeber, I; Guhl, E; Heuer, D; Jansen, K; Selb, R; Tamminga, T	1
Dresser, J; Wilby, KJ	1
Adelman, E; Barber, L; Bautista, I; Bendik, W; Griego, R; Hansen, H; Kersh, EN; Knoblock, RJ; Lam, K; Pham, CD; Picker, MA; Qiu-Shultz, Z; Raphael, BH; St Cyr, SB; Weinstock, H	1
Cole, MJ; Day, M; Jacobsson, S; Spiteri, G; Unemo, M	1
Abbai, NS; Maise, HC; Naicker, M; Oree, G; Ramsuran, V; Tinarwo, P	1
Abe, S; Amarasiri, M; Badavath, VN; Chantaravisoot, N; Chatsuwan, T; Higgins, PG; Hongsing, P; Hurst, C; Jenjaroenpun, P; Kerr, SJ; Kueakulpattana, N; Luk-In, S; Phattharapornjaroen, P; Saethang, T; Shein, AMS; Teeratakulpisan, N; Wannigama, DL; Wongsurawat, T	1
Bonongwe, N; Chen, JS; Chikaonda, T; Cohen, MS; Golparian, D; Hobbs, MM; Hoffman, IF; Jere, E; Kamtambe, B; Krysiak, R; Massa, C; Mathiya, E; Matoga, M; Ndalama, B; Unemo, M	1
Allen, H; Cole, MJ; Fifer, H; Hughes, G; Ivanov, Z; Merrick, R; Mohammed, H; Pitt, R; Sinka, K	1
Cai, C; Cao, W; Chen, H; Guo, C; Li, M; Liao, Y; Lin, X; Liu, X; Pei, J; Qin, X; Tang, S; Wang, F; Wu, S; Wu, X; Wu, Z; Xie, Q; Yu, Y; Zheng, H	1
Cole, MJ; Dillon, JR; Eremin, S; Escher, M; Galarza, P; Galas, M; Lahra, MM; Martin, I; Ndowa, F; Ramon-Pardo, P; Unemo, M; Weinstock, H; Wi, T	1
Aanensen, DM; Abudahab, K; Bluemel, B; Cole, MJ; Day, M; Golparian, D; Jacobsson, S; Sajedi, N; Sánchez-Busó, L; Spiteri, G; Underwood, A; Unemo, M; Yeats, CA	1
Amato-Gauci, AJ; Blumel, B; Cole, MJ; Day, MJ; Jacobsson, S; Kulishev, C; Sajedi, N; Spiteri, G; Unemo, M; van der Werf, MJ; Woodford, N	1
Nguyen, HT; Nguyen, HV; Nguyen, PTT; Pham, HV; Pham, LV; Van, DH	1
Adamson, PC; Allan-Blitz, LT; Klausner, JD	1
Barrios-Cárdenas, YJ; Benites, C; Jorge-Berrocal, A; Mayta-Barrios, M; Melano, RG; Salazar-Quispe, F; Vargas-Herrera, N; Yagui, M	1
Jenjaroenpun, P; Nitayanon, P; Nokchan, N; Tribuddharat, C; Wongsurawat, T	1
Akeda, Y; Nakayama, SI; Ohnishi, M; Shimuta, K; Takahashi, H	1
Kiamos, A; Sands, M; Torrente, N; Verdecia, J	1
Kowalewski, C; Krolak-Ulinska, A; Marusza, W; Mlynarczyk-Bonikowska, B	1
Alvarado, L; Burghardt, NO; Hernandez, C; Hughes, B; Jacobson, KR; Jenkins-Barnes, T; Johnson, KA; Lopez, E; Salas, KL; Tang, EC	1
Debelo, M; Mohammed, N; Tiruneh, A; Tolosa, T	1
Chow, EPF; Fairley, CK; Hammoud, MA; Hocking, JS; Kong, FYS; Landersdorfer, CB; Latch, N; Lewis, DA; Lim, SH; Parker, SL; Roberts, JA; Unemo, M; Wallis, SC; Williamson, DA; Yap, T	1
Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N	1
Bristow, CC; Klausner, JD; Kojima, N; Yang, KJ	1
Cao, W; Dong, Y; Gu, W; Hu, L; Huang, J; Li, Y; Peng, J; Wang, L; Wang, Y; Xiu, L; Yong, G	1
Ahmad, M; Shah, N; Siddiqui, MA	1
Jain, SH; Lee, CY; Li, JW; Lin, HH; Lin, SY; Lu, PL; Yang, TY	1
Allen, H; Althaus, CL; Cole, MJ; Grad, YH; Heijne, JCM; Low, N; Riou, J; Unemo, M	1
Feng, Z; Li, X; Liao, Y; Liu, M; Pan, Y; Qin, X; Wu, X; Xie, Q; Yang, J; Yin, X; Zeng, L; Zheng, H	1
Chen, W; Li, R; Lin, X; Liu, X; Luo, X; Tang, Y; Zhuang, P	1
Blouin, K; Defay, F; Ezin Aloffan, LND; Labbé, AC; Lefebvre, B; Perrault Sullivan, G; Trudelle, A	1
Chokyu, H; Fujita, R; Hamasuna, R; Hanaki, H; Hara, M; Hatano, K; Hayami, H; Hayashi, K; Hirayama, H; Hiyama, Y; Hosobe, T; Ihara, H; Inokuchi, J; Ishikawa, K; Ito, K; Ito, M; Ito, S; Izumitani, M; Kadena, H; Kaji, S; Kano, M; Kawahara, M; Kawai, S; Kimura, T; Kiyota, H; Kobayashi, K; Kurimura, Y; Maruyama, T; Masumori, N; Matsumoto, K; Matsumoto, M; Matsumoto, T; Matsumura, M; Miyazaki, J; Monden, K; Naito, K; Nishi, S; Nishimura, H; Nishiyama, H; Sadahira, T; Sato, J; Shiono, Y; Sumii, T; Takahashi, S; Takayama, K; Tanaka, K; Togo, Y; Tojo, T; Uno, S; Wada, K; Yamada, H; Yamamoto, S; Yasuda, M; Yoh, M; Yokoyama, T; Yotsuyanagi, H	1
Dingle, TC; Ferrato, C; Gratrix, J; Ma, A; Martin, I; Smyczek, P	1

Reviews

12 review(s) available for cefixime and ro13-9904

Article	Year
[Whipple's disease]. Praxis, 2007, Jan-10, Volume: 96, Issue:1-2 Topics: Anti-Bacterial Agents; Biopsy; Cefixime; Ceftriaxone; Clinical Trials as Topic; Doxycycline; Duodenum; Humans; Intestinal Mucosa; Jejunum; Male; Meropenem; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Thienamycins; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Whipple Disease	2007
Acute pyelonephritis in children: antibiotic therapy depending on the clinical context. Prescrire international, 2010, Volume: 19, Issue:108 Topics: Acute Disease; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Child; Child, Preschool; Humans; Microbial Sensitivity Tests; Practice Guidelines as Topic; Pyelonephritis; Risk Factors	2010
Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management. Expert review of anti-infective therapy, 2011, Volume: 9, Issue:10 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Disease Management; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Microbial Interactions; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Plasmids; Population Surveillance; Public Health; Treatment Failure; United Kingdom	2011
Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea: a meta-analysis of randomized controlled trials. International journal of STD & AIDS, 2012, Volume: 23, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Gonorrhea; Humans; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Spectinomycin; Treatment Outcome	2012
Preparing for an era of untreatable gonorrhea. Current opinion in infectious diseases, 2014, Volume: 27, Issue:3 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Drug Administration Schedule; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharynx; Population Surveillance; Practice Guidelines as Topic; Public Health; Treatment Failure	2014
Salmonella pneumonia complicated with encysted empyema in an immunocompromised youth: Case report and literature Review. Journal of infection in developing countries, 2016, Apr-28, Volume: 10, Issue:4 Topics: Anti-Bacterial Agents; Bahrain; Cefixime; Ceftriaxone; Empyema; Hodgkin Disease; Humans; Male; Pneumonia, Bacterial; Salmonella enteritidis; Salmonella Infections; Sputum; Young Adult	2016
Antibiotics for treating gonorrhoea in pregnancy. The Cochrane database of systematic reviews, 2018, 02-21, Volume: 2 Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Female; Gonorrhea; Humans; Pregnancy; Pregnancy Complications, Infectious; Probenecid; Randomized Controlled Trials as Topic; Spectinomycin	2018
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century. Medical microbiology and immunology, 2020, Volume: 209, Issue:2 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Europe; Genotype; Gonorrhea; Humans; Neisseria gonorrhoeae; Penicillins	2020
Safety of Single-Dose Oral Cefixime, Intramuscular Ceftriaxone, or Intramuscular Gentamicin for the Treatment of Gonorrhea: A Systematic Review and Meta-analysis. The Annals of pharmacotherapy, 2021, Volume: 55, Issue:7 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Gentamicins; Gonorrhea; Humans; Injections, Intramuscular	2021
Molecular Mechanisms of Drug Resistance and Epidemiology of Multidrug-Resistant Variants of International journal of molecular sciences, 2022, Sep-10, Volume: 23, Issue:18 Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Cefixime; Ceftriaxone; Drug Resistance; Drug Resistance, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillinase; Penicillins; Peptidyl Transferases	2022
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever	2022
Effectiveness of Cefixime for the Treatment of Neisseria gonorrhoeae Infection at 3 Anatomic Sites: A Systematic Review and Meta-Analysis. Sexually transmitted diseases, 2023, 03-01, Volume: 50, Issue:3 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Treatment Outcome	2023

Trials

16 trial(s) available for cefixime and ro13-9904

Article	Year
Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection. The Journal of infectious diseases, 1992, Volume: 166, Issue:4 Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftriaxone; Drug Evaluation; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Urethritis; Uterine Cervicitis	1992
Cefixime offers effective oral therapy for gonorrhea. The Nurse practitioner, 1992, Volume: 17, Issue:5 Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Ceftriaxone; Female; Gonorrhea; Humans; Male	1992
A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group. The New England journal of medicine, 1991, Nov-07, Volume: 325, Issue:19 Topics: Administration, Oral; Adolescent; Adult; Cefixime; Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; Drug Tolerance; Female; Gonorrhea; Humans; Injections, Intramuscular; Male	1991
[Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections]. Presse medicale (Paris, France : 1983), 1989, Oct-11, Volume: 18, Issue:32 Topics: Administration, Oral; Cefixime; Cefotaxime; Ceftriaxone; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Random Allocation; Urinary Tract Infections	1989
Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children. The Pediatric infectious disease journal, 1995, Volume: 14, Issue:7 Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Resistance, Multiple; Egypt; Female; Humans; Male; Monobactams; Salmonella typhi; Treatment Outcome; Typhoid Fever	1995
Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone. The Pediatric infectious disease journal, 1994, Volume: 13, Issue:11 Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftriaxone; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Infant; Injections, Intravenous; Male; Salmonella typhi; Typhoid Fever	1994
Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease. Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:3 Topics: Administration, Oral; Adolescent; Anemia, Sickle Cell; Anti-Infective Agents; Bacteremia; Bacterial Infections; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Outpatients; Patient Compliance	1996
Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia. Clinical pediatrics, 1996, Volume: 35, Issue:12 Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Penicillins; Pneumonia, Pneumococcal; Radiography	1996
Plasma cytokines in paediatric typhoidal salmonellosis: correlation with clinical course and outcome. The Journal of infection, 1997, Volume: 35, Issue:3 Topics: Adolescent; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Interleukin-6; Male; Morbidity; Salmonella typhi; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Typhoid Fever	1997
Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:10 Topics: Administration, Oral; Adult; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intravenous; Lyme Disease; Penicillins; Probenecid; Renal Agents; Treatment Outcome	1998
Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens. International journal of antimicrobial agents, 2001, Volume: 17, Issue:6 Topics: Administration, Oral; Adult; Blood Bactericidal Activity; Cefixime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross-Over Studies; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae	2001
A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy. American journal of obstetrics and gynecology, 2001, Volume: 185, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Anus Diseases; Cefixime; Ceftriaxone; Cephalosporins; Chlamydia Infections; Female; Gonorrhea; Humans; Injections, Intramuscular; Pharyngeal Diseases; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Treatment Outcome; Uterine Cervical Diseases	2001
Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial. Emergency medicine journal : EMJ, 2002, Volume: 19, Issue:1 Topics: Acute Disease; Adult; Cefixime; Ceftriaxone; Cephalosporins; Female; Humans; Middle Aged; Prospective Studies; Pyelonephritis	2002
Randomized trial of oral versus sequential IV/oral antibiotic for acute pyelonephritis in children. Pediatrics, 2012, Volume: 129, Issue:2 Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Calcitonin; Calcitonin Gene-Related Peptide; Cefixime; Ceftriaxone; Child, Preschool; Drug Administration Schedule; Escherichia coli Infections; Female; Humans; Infant; Infusions, Intravenous; Male; Prospective Studies; Protein Precursors; Pyelonephritis; Radionuclide Imaging	2012
Randomized controlled trial of the relative efficacy of high-dose intravenous ceftriaxone and oral cefixime combined with doxycycline for the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae co-infection. BMC infectious diseases, 2022, Jul-09, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Chlamydia Infections; Chlamydia trachomatis; Coinfection; Doxycycline; Gonorrhea; Humans; Neisseria gonorrhoeae	2022
Optimisation of treatments for oral BMJ open, 2022, Nov-11, Volume: 12, Issue:11 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Gonorrhea; Humans; Male; Neisseria gonorrhoeae	2022

Other Studies

117 other study(ies) available for cefixime and ro13-9904

Article	Year
Sexually transmitted diseases in the 1990s. The New England journal of medicine, 1991, Nov-07, Volume: 325, Issue:19 Topics: Cefixime; Cefotaxime; Ceftriaxone; Gonorrhea; HIV Infections; Humans; Sexually Transmitted Diseases	1991
Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:7 Topics: Ampicillin Resistance; beta-Lactamases; Cefixime; Cefotaxime; Ceftriaxone; Haemophilus Infections; Haemophilus influenzae; Microbial Sensitivity Tests	1990
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2 Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V	1986
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:12 Topics: Bacteria; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Microbial Sensitivity Tests	1988
Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance. Chemotherapy, 1988, Volume: 34, Issue:3 Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Plasmids	1988
Living with Lyme. Lancet (London, England), 1995, Apr-01, Volume: 345, Issue:8953 Topics: Adaptation, Psychological; Adult; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Finland; History, 20th Century; Humans; Lyme Disease; Male	1995
Cost-effectiveness decision analysis of intramuscular ceftriaxone versus oral cefixime in adolescents with gonococcal cervicitis. Annals of emergency medicine, 1996, Volume: 27, Issue:3 Topics: Administration, Oral; Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Cost of Illness; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Female; Gonorrhea; Humans; Injections, Intramuscular; Treatment Outcome; Uterine Cervicitis	1996
Cerebral relapse of sarcoidlike Whipple's disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:6 Topics: Brain Diseases; Cefixime; Cefotaxime; Ceftriaxone; Diagnosis, Differential; Humans; Male; Middle Aged; Recurrence; Sarcoidosis; Whipple Disease	1997
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae	1998
HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms. Journal of pharmaceutical and biomedical analysis, 1998, Volume: 18, Issue:4-5 Topics: Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Dosage Forms; Reproducibility of Results; Sensitivity and Specificity	1998
Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:7 Topics: Animals; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Humans; Microbial Sensitivity Tests; Yersinia pestis	2000
Salmonella typhiin the past decade: learning to live with resistance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Jan-01, Volume: 34, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Salmonella typhi; Typhoid Fever	2002
Sexually transmitted disease guidelines focus on prevention. Report on medical guidelines & outcomes research, 2002, Jun-14, Volume: 13, Issue:11 Topics: Bisexuality; California; Cefixime; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Drug Resistance, Bacterial; Female; Fluoroquinolones; Homosexuality, Male; Humans; Infertility; Male; Mass Screening; Pelvic Inflammatory Disease; Practice Guidelines as Topic; Risk Factors; Sexually Transmitted Diseases; United States	2002
Increasing cases of drug-resistant gonorrhea prompt new CDC treatment recommendations for gay and bisexual men. Report on medical guidelines & outcomes research, 2004, May-14, Volume: 15, Issue:10 Topics: Cefixime; Ceftizoxime; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Contraindications; Drug Resistance; Fluoroquinolones; Gonorrhea; Heterosexuality; Homosexuality, Male; Humans; Male; Practice Guidelines as Topic; United States	2004
[Management of acute pyelonephritis in patients older than 3 months: survey conducted in 39 paediatric emergency departments of the Ile de France Region in 2004]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2006, Volume: 13, Issue:3 Topics: Acute Disease; Administration, Oral; Adolescent; Age Factors; Anti-Bacterial Agents; Cefaclor; Cefixime; Ceftriaxone; Child; Child, Preschool; Data Collection; Drug Therapy, Combination; Emergency Service, Hospital; Follow-Up Studies; France; Humans; Infant; Infusions, Parenteral; Injections, Intravenous; Intensive Care Units, Pediatric; Outpatients; Pyelonephritis; Surveys and Questionnaires; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Ultrasonography; Urethra; Urinary Bladder; Urography	2006
Gonorrhea: update. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2006, Volume: 101, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Child; Gonorrhea; Humans; Incidence; Infection Control, Dental; Neisseria gonorrhoeae; Oral Ulcer; Pharyngitis; Prevalence; United States	2006
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Polymorphism, Genetic; Porins; Repressor Proteins	2007
Threat to cefixime treatment for gonorrhea. Emerging infectious diseases, 2007, Volume: 13, Issue:8 Topics: Adult; Base Sequence; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae	2007
Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2007, Volume: 13, Issue:5 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Japan; Male; Microbial Sensitivity Tests; Mouth; Neisseria; Penicillins; Tetracycline	2007
Acute septic arthritis: remember gonorrhea. Rheumatology international, 2008, Volume: 29, Issue:1 Topics: Acute Disease; Anti-Bacterial Agents; Arthritis, Infectious; Cefixime; Ceftriaxone; Gonorrhea; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Treatment Outcome	2008
Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2008, Volume: 14, Issue:3 Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Sequence Analysis, Protein; Urethritis	2008
Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci. Sexually transmitted infections, 2009, Volume: 85, Issue:4 Topics: Anti-Bacterial Agents; Asia, Southeastern; Australia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Dose-Response Relationship, Drug; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pacific Islands; Treatment Failure; World Health Organization	2009
Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9 Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance	2009
Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone. Talanta, 2009, Nov-15, Volume: 80, Issue:1 Topics: Amniotic Fluid; Calibration; Cefepime; Cefixime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Molecular Structure; Pregnancy; Reproducibility of Results; Temperature	2009
Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:4 Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Bacterial Typing Techniques; Cefixime; Ceftriaxone; DNA Fingerprinting; DNA, Bacterial; Genotype; Humans; Korea; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Neisseria gonorrhoeae; Sequence Analysis, DNA	2010
Diagnosis and treatment of urethritis in men. American family physician, 2010, Apr-01, Volume: 81, Issue:7 Topics: Adolescent; Adult; Azithromycin; Black or African American; Cefixime; Ceftriaxone; Chlamydia Infections; Chlamydia trachomatis; Contact Tracing; Doxycycline; Drug Therapy, Combination; Gonorrhea; HIV Infections; Humans; Male; Mycoplasma Infections; Ureaplasma Infections; Urethritis; White People; Young Adult	2010
A novel sensor for cephalosporins based on electrocatalytic oxidation by poly(o-anisidine)/SDS/Ni modified carbon paste electrode. Talanta, 2010, Jun-15, Volume: 81, Issue:4-5 Topics: Aniline Compounds; Biosensing Techniques; Catalysis; Cefixime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chemistry Techniques, Analytical; Electrochemistry; Electrodes; Models, Chemical; Nickel; Oxygen; Sodium Dodecyl Sulfate; Solvents	2010
Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry, 2010, Sep-21, Volume: 49, Issue:37 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Penicillins	2010
Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sexually transmitted infections, 2010, Volume: 86, Issue:6 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Cefixime; Ceftriaxone; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Female; Genome, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Neisseria gonorrhoeae; Phylogeny; Sweden; Young Adult	2010
Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:12 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporin Resistance; Fimbriae Proteins; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Neisseria gonorrhoeae	2010
Quick recertification series. Gonorrhea. JAAPA : official journal of the American Academy of Physician Assistants, 2010, Volume: 23, Issue:11 Topics: Administration, Oral; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Risk Factors	2010
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Neisseria gonorrhoeae; Ontario; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sequence Analysis, DNA	2011
Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2010, Nov-25, Volume: 15, Issue:47 Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norway; Polymerase Chain Reaction; Treatment Failure	2010
Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2011, Volume: 119, Issue:6 Topics: Alleles; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gonorrhea; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Sequence Analysis, DNA	2011
Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010. MMWR. Morbidity and mortality weekly report, 2011, Jul-08, Volume: 60, Issue:26 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Population Surveillance; United States	2011
Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Italy; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Typing; Mutant Proteins; Neisseria gonorrhoeae; Sequence Analysis, DNA	2012
Characterization of profile of multidrug-resistant Neisseria gonorrhoeae using old and new definitions in India over a decade: 2000-2009. Sexually transmitted diseases, 2011, Volume: 38, Issue:11 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; India; Microbial Sensitivity Tests; Neisseria gonorrhoeae	2011
High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Alleles; Amino Acid Sequence; Anti-Bacterial Agents; Biomarkers; Cefixime; Ceftriaxone; Cephalosporin Resistance; France; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mosaicism; Multilocus Sequence Typing; Neisseria gonorrhoeae; Population Surveillance; Porins; Treatment Failure	2012
Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010. Sexually transmitted diseases, 2012, Volume: 39, Issue:4 Topics: Adolescent; Adult; Canada; Cefixime; Ceftriaxone; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult	2012
Management of pharyngeal gonorrhea is crucial to prevent the emergence and spread of antibiotic-resistant Neisseria gonorrhoeae. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:7 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporin Resistance; Gonorrhea; Humans; Male; Neisseria gonorrhoeae	2012
Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR. Morbidity and mortality weekly report, 2012, Aug-10, Volume: 61, Issue:31 Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Doxycycline; Drug Administration Schedule; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Neisseria gonorrhoeae; United States	2012
Tackling multidrug-resistant gonorrhea: how should we prepare for the untreatable? Expert review of anti-infective therapy, 2012, Volume: 10, Issue:8 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Public Health; Treatment Failure	2012
Combination therapy for gonorrhoea: in vitro synergy testing. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:3 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Synergism; Gentamicins; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; United Kingdom	2013
Update on Emerging Infections: news from the Centers for Disease Control and Prevention. Update to the CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections . Annals of emergency medicine, 2013, Volume: 61, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Doxycycline; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae	2013
Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011. The Lancet. Infectious diseases, 2013, Volume: 13, Issue:9 Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; England; Female; Genes, Bacterial; Gonorrhea; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Porins; Prevalence; Risk Factors; Sexual Behavior; Wales; Young Adult	2013
Cephalosporin resistance in gonorrhoea. The Lancet. Infectious diseases, 2013, Volume: 13, Issue:9 Topics: Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae	2013
Mixed Salmonella infection: a report of two cases from the Aga Khan University Hospital, Karachi. JPMA. The Journal of the Pakistan Medical Association, 2013, Volume: 63, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; Cefixime; Ceftriaxone; Child, Preschool; Female; Fever; Humans; Male; Microbial Sensitivity Tests; Salmonella Infections; Salmonella paratyphi A; Salmonella typhi	2013
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11 Topics: Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; beta-Lactam Resistance; Cefixime; Ceftriaxone; Ciprofloxacin; Epidemiological Monitoring; Female; Gonorrhea; Humans; Incidence; Japan; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillin G	2013
Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada. Sexually transmitted diseases, 2013, Volume: 40, Issue:9 Topics: Alberta; Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gonorrhea; Heterosexuality; Homosexuality, Female; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Phylogeny; Retrospective Studies	2013
Gonococcal susceptibility to cephalosporins--Hawaii, 2003 to 2011. Sexually transmitted diseases, 2013, Volume: 40, Issue:9 Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Drug Resistance, Bacterial; Female; Gonorrhea; Hawaii; Heterosexuality; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Population Surveillance; Prevalence; Young Adult	2013
Does the '2012 IUSTI ECCG report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe' depict the situation in Europe? International journal of STD & AIDS, 2013, Volume: 24, Issue:6 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Disease Management; Europe; Gonorrhea; Health Services Accessibility; Health Surveys; Humans; Neisseria gonorrhoeae; Nucleic Acid Amplification Techniques; Surveys and Questionnaires	2013
Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012. BMC infectious diseases, 2013, Dec-26, Volume: 13 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Switzerland; Young Adult	2013
Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally. Sexually transmitted infections, 2014, Volume: 90, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; DNA, Bacterial; Female; Gonorrhea; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Neisseria gonorrhoeae; Penicillins; Saskatchewan; Sequence Analysis, DNA; Spectinomycin; Tetracycline; Young Adult	2014
Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:6 Topics: Amino Acid Substitution; Bacterial Proteins; Canada; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae	2014
Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins. BMC infectious diseases, 2014, Feb-25, Volume: 14 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Phenotype; Switzerland; Tetracycline; Young Adult	2014
Decreased susceptibility to cephalosporins among gonococci? The Lancet. Infectious diseases, 2014, Volume: 14, Issue:3 Topics: Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae	2014
Decreased susceptibility to cephalosporins among gonococci? The Lancet. Infectious diseases, 2014, Volume: 14, Issue:3 Topics: Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae	2014
Decreased susceptibility to cephalosporins among gonococci? Authors' reply. The Lancet. Infectious diseases, 2014, Volume: 14, Issue:3 Topics: Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae	2014
Decreased susceptibility to cephalosporins among gonococci? The Lancet. Infectious diseases, 2014, Volume: 14, Issue:3 Topics: Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae	2014
Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:8 Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Japan; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Promoter Regions, Genetic; Repressor Proteins; RNA, Ribosomal, 23S; Spectinomycin; Treatment Failure	2014
Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2014, Nov-13, Volume: 19, Issue:45 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Europe; European Union; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance	2014
Changes in the six most common sequence types of Neisseria gonorrhoeae, including ST4378, identified by surveillance of antimicrobial resistance in northern Taiwan from 2006 to 2013. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:5 Topics: Anti-Bacterial Agents; Antigens, Bacterial; Cefixime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Ciprofloxacin; Condoms; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillins; Sexual and Gender Minorities; Taiwan; Unsafe Sex	2016
Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe. Sexually transmitted diseases, 2014, Volume: 41, Issue:12 Topics: Adult; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Microbial; Europe; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Risk Factors; Sentinel Surveillance	2014
The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:5 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Population Surveillance; Urethritis; Young Adult	2015
High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9 Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Humans; Isoxazoles; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds	2015
Brain abscess due to Aggregatibacter aphrophilus and Bacteroides uniformis. Acta medica academica, 2015, Volume: 44, Issue:2 Topics: Adolescent; Aggregatibacter aphrophilus; Anti-Bacterial Agents; Bacteroides; Bacteroides Infections; Brain Abscess; Cefixime; Ceftriaxone; Coinfection; Craniotomy; Drainage; Humans; Magnetic Resonance Imaging; Male; Metronidazole; Pasteurellaceae Infections	2015
Shigella infections: A two year experience in cancer patients. JPMA. The Journal of the Pakistan Medical Association, 2016, Volume: 66, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Child; Child, Preschool; Comorbidity; Drug Resistance, Bacterial; Dysentery, Bacillary; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Pakistan; Retrospective Studies; Shigella flexneri; Young Adult	2016
Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina. Emerging infectious diseases, 2016, Volume: 22, Issue:6 Topics: Alleles; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; Cefixime; Ceftriaxone; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Young Adult	2016
Genetic Resistance Determinants for Cefixime and Molecular Analysis of Gonococci Isolated in Italy. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:2 Topics: Alleles; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Genotype; Gonorrhea; Humans; Italy; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Promoter Regions, Genetic	2017
Ceftriaxone-Resistant Neisseria gonorrhoeae Isolates (2010 to 2014) in France Characterized by Using Whole-Genome Sequencing. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cell Cycle Proteins; Cephalosporin Resistance; France; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Neisseria gonorrhoeae	2016
Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae. BMC microbiology, 2016, 09-17, Volume: 16 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cell Count; Cell Survival; Chloramphenicol; Ciprofloxacin; Gentamicins; Growth Charts; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Models, Theoretical; Neisseria gonorrhoeae; Penicillin G; Spectinomycin; Tetracycline; Time Factors	2016
Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary. Annals of clinical microbiology and antimicrobials, 2016, Sep-20, Volume: 15, Issue:1 Topics: Adult; Alleles; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gene Expression; Gonorrhea; Humans; Hungary; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Phylogeny; Porins; Prevalence; Spectinomycin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetracycline; Transferrin-Binding Protein B	2016
Reduced susceptibility to cefixime but not ceftriaxone: an uncertain perspective for the treatment of gonorrhoea in Brazil. International journal of antimicrobial agents, 2017, Volume: 49, Issue:4 Topics: Adult; Anti-Bacterial Agents; Brazil; Cefixime; Ceftriaxone; Female; Gonorrhea; High-Throughput Nucleotide Sequencing; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Neisseria gonorrhoeae; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Whole Genome Sequencing; Young Adult	2017
Antimicrobial Susceptibility Evaluation and Multiple-Locus Variable Number Tandem Repeat Analysis of Neisseria gonorrhoeae Isolates in China in 2012. Sexually transmitted diseases, 2017, Volume: 44, Issue:4 Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cervix Uteri; Chi-Square Distribution; China; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Neisseria gonorrhoeae; Penicillins; Prevalence; Spectinomycin; Tetracycline; Urethra; Young Adult	2017
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy. Balkan medical journal, 2017, Sep-29, Volume: 34, Issue:5 Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefixime; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Pediatrics; Retrospective Studies; Sulfamethizole; Trimethoprim; Turkey; Urinary Tract Infections	2017
Antimicrobial susceptibility in Sexually transmitted infections, 2018, Volume: 94, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult; Zimbabwe	2018
Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013. Sexually transmitted diseases, 2017, Volume: 44, Issue:6 Topics: Anti-Bacterial Agents; Argentina; Cefixime; Ceftriaxone; Cephalosporin Resistance; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Typing; Neisseria gonorrhoeae; Phylogeny; Sentinel Surveillance; Sequence Analysis, DNA	2017
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015. BMC infectious diseases, 2017, 09-11, Volume: 17, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Female; Gonorrhea; Heterosexuality; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult	2017
High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment? The Journal of antimicrobial chemotherapy, 2018, Jan-01, Volume: 73, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Point-of-Care Systems; Retrospective Studies; Saskatchewan; Spectinomycin; Young Adult	2018
Accuracy and reproducibility of the Etest to detect drug-resistant Neisseria gonorrhoeae to contemporary treatment. Journal of medical microbiology, 2018, Volume: 67, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Reproducibility of Results	2018
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance. BMC infectious diseases, 2018, 01-17, Volume: 18, Issue:1 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cervix Uteri; Ciprofloxacin; Female; Germany; Gonorrhea; Humans; Laboratories; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Rectum; Urethra; Vagina; Young Adult	2018
Transfer of a gonococcal β-lactamase plasmid into Neisseria gonorrhoeae belonging to the globally distributed ST1407 lineage. The Journal of antimicrobial chemotherapy, 2018, 09-01, Volume: 73, Issue:9 Topics: beta-Lactamases; Cefixime; Ceftriaxone; Ciprofloxacin; Gene Transfer, Horizontal; Genotype; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Plasmids	2018
Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996-2016. Journal of global antimicrobial resistance, 2019, Volume: 17 Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Japan; Microbial Sensitivity Tests; Neisseria gonorrhoeae	2019
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016. BMC infectious diseases, 2018, Dec-03, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Europe; Female; Gentamicins; Gonorrhea; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Spectinomycin; Young Adult	2018
Recognition of the β-lactam carboxylate triggers acylation of The Journal of biological chemistry, 2019, 09-20, Volume: 294, Issue:38 Topics: Acylation; Alleles; Binding Sites; Catalytic Domain; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Gonorrhea; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Serine-Type D-Ala-D-Ala Carboxypeptidase	2019
Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae. The Journal of infectious diseases, 2020, 02-18, Volume: 221, Issue:5 Topics: Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Codon; Evolution, Molecular; Gonorrhea; Humans; Neisseria gonorrhoeae; United States	2020
Antimicrobial resistance of Neisseria gonorrhoeae in Jakarta, Indonesia: a cross-sectional study. Sexual health, 2020, Volume: 17, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Indonesia; Levofloxacin; Male; Middle Aged; Neisseria gonorrhoeae; Penicillins; Tetracycline	2020
First Case of High-Level Azithromycin-Resistant Neisseria gonorrhoeae in North Carolina. Sexually transmitted diseases, 2020, Volume: 47, Issue:5 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; HIV Seronegativity; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; North Carolina; Penicillins; Pharynx; Tetracycline; Whole Genome Sequencing	2020
Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report. JMIR public health and surveillance, 2020, 06-10, Volume: 6, Issue:2 Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Demography; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillin G; Population Surveillance; Sentinel Surveillance; Spectinomycin; Tetracycline; Uganda	2020
Cephalosporin-Resistant Neisseria gonorrhoeae Isolated in Portugal, 2019. Sexually transmitted diseases, 2020, Volume: 47, Issue:11 Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Portugal	2020
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany. BMC infectious diseases, 2020, Jul-16, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Germany; Gonorrhea; Humans; Laboratories; Laboratory Proficiency Testing; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Quality Control; Reference Standards; Surveys and Questionnaires	2020
Notes from the Field: First Case in the United States of Neisseria gonorrhoeae Harboring Emerging Mosaic penA60 Allele, Conferring Reduced Susceptibility to Cefixime and Ceftriaxone. MMWR. Morbidity and mortality weekly report, 2020, 12-11, Volume: 69, Issue:49 Topics: Alleles; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; United States	2020
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016. BMC infectious diseases, 2021, Mar-18, Volume: 21, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; European Union; Female; Gonorrhea; Heterosexuality; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sex Factors; Sexual and Gender Minorities; Sexual Behavior	2021
Tracking Antimicrobial Resistance in Neisseria gonorrhoeae from the Molecular Level Using Endocervical Swabs. Laboratory medicine, 2022, Jan-06, Volume: 53, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pregnancy; Spectinomycin	2022
Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand. Scientific reports, 2021, 11-04, Volume: 11, Issue:1 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gonorrhea; Heterosexuality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Docking Simulation; Neisseria gonorrhoeae; Thailand	2021
Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi. Sexually transmitted diseases, 2022, 04-01, Volume: 49, Issue:4 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Female; Gentamicins; Gonorrhea; Humans; Malawi; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Polymorphism, Single Nucleotide; Spectinomycin; Tetracycline; Treatment Outcome	2022
Is there an association between previous infection with Sexually transmitted infections, 2023, Volume: 99, Issue:1 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cross-Sectional Studies; Drug Resistance, Bacterial; England; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance; Sexual and Gender Minorities	2023
Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020. Antimicrobial agents and chemotherapy, 2022, 04-19, Volume: 66, Issue:4 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; China; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae	2022
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study. The Lancet. Microbe, 2021, Volume: 2, Issue:11 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Neisseria gonorrhoeae; World Health Organization	2021
Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study. The Lancet. Microbe, 2022, Volume: 3, Issue:6 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Europe; Genomics; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sexual and Gender Minorities	2022
Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019. BMC infectious diseases, 2022, Jun-07, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharyngitis; Sexual and Gender Minorities	2022
Resistance-Guided Therapy for Neisseria gonorrhoeae. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-29, Volume: 75, Issue:9 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae	2022
Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates From Peru, 2018 and 2019. Sexually transmitted diseases, 2022, 10-01, Volume: 49, Issue:10 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Peru; Spectinomycin	2022
Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand. PloS one, 2022, Volume: 17, Issue:7 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Sequence Analysis; Spectinomycin; Tetracycline; Thailand	2022
Loop-Mediated Isothermal Amplification Assay for Identifying Neisseria gonorrhoeae Nonmosaic Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae	2022
Right hip gonococcal septic arthritis treatment with successful transition to oral fluoroquinolone. BMJ case reports, 2022, Sep-16, Volume: 15, Issue:9 Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Levofloxacin; Tetracycline	2022
Characterizing the Rise of Disseminated Gonococcal Infections in California, July 2020-July 2021. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 01-13, Volume: 76, Issue:2 Topics: Adult; Anti-Bacterial Agents; California; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae	2023
Isolation, identification and antibiotic resistance profile of thermophilic Campylobacter species from Bovine, Knives and personnel at Jimma Town Abattoir, Ethiopia. PloS one, 2022, Volume: 17, Issue:10 Topics: Abattoirs; Agar; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cattle; Cefixime; Ceftriaxone; Cephalothin; Chloramphenicol; Ciprofloxacin; Clindamycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Microbial; Ethiopia; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline	2022
Multicentre Clinical Evaluation of a Molecular Diagnostic Assay to Identify Neisseria gonorrhoeae Infection and Detect Antimicrobial Resistance. International journal of antimicrobial agents, 2023, Volume: 61, Issue:5 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pathology, Molecular	2023
Frequency and Antibiotics Sensitivity Pattern of Culture-Positive Salmonella Typhi in Children. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2023, Volume: 33, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever	2023
Emergence of a predominant sequence type ST7363 and the increasing trend of resistance to cefixime and ceftriaxone in Neisseria gonorrhoeae in Southern Taiwan, 2019-2021. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2023, Volume: 56, Issue:4 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Taiwan	2023
Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study. BMC infectious diseases, 2023, Apr-20, Volume: 23, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sexual and Gender Minorities	2023
Dissemination of Neisseria gonorrhoeae with decreased susceptibility to extended-spectrum cephalosporins in Southern China, 2021: a genome-wide surveillance from 20 cities. Annals of clinical microbiology and antimicrobials, 2023, May-17, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Cities; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Phylogeny	2023
Antimicrobial Resistance Profiling and Genome Analysis of the penA-60.001 Neisseria gonorrhoeae Clinical Isolates in China in 2021. The Journal of infectious diseases, 2023, 09-15, Volume: 228, Issue:6 Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae	2023
Correlates of BMJ open, 2023, 08-04, Volume: 13, Issue:8 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gonorrhea; HIV Infections; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quebec; Sentinel Surveillance; Sexual and Gender Minorities	2023
The third nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2016-2017. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:11 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Gonorrhea; Humans; Japan; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Spectinomycin; Urethritis	2023
Use of genome sequencing to resolve differences in gradient diffusion and agar dilution antimicrobial susceptibility testing performance of Journal of clinical microbiology, 2023, Nov-21, Volume: 61, Issue:11 Topics: Agar; Alberta; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Retrospective Studies; Tetracycline	2023